An Introduction to Risk-Based Quality Management in CDM [Video]

Risk-based quality management in clinical data management is a structured way to focus quality oversight on the data and processes that matter most to participant safety and to the reliability of trial results. In this explainer, we break down how RBQM works in practice, why it matters in day-to-day CDM, and what teams need to control to keep monitoring meaningful, proportionate, and useful across the life of a study.

What This Video Covers
• What risk-based quality management means in clinical data management
• How teams identify critical data, critical processes, and meaningful risks
• How KRIs, QTLs, and central review support ongoing oversight
• What a practical risk monitoring plan should include
• Common pitfalls, including too many metrics, static plans, and late reactive clean-up

A strong RBQM approach helps teams focus effort where the consequences are highest, define actions before thresholds are breached, and keep oversight aligned as studies evolve. That depends on clear risk assessment, actionable monitoring, documented decisions, and close coordination across data management, clinical operations, and other delivery functions.

At Quanticate, our biometrics and clinical teams support sponsors with practical, rigorous support across clinical trials and regulated development. Request a consultation today.